Cargando…
Erratum for “Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061164/ https://www.ncbi.nlm.nih.gov/pubmed/36805657 http://dx.doi.org/10.1111/jvim.16667 |
Ejemplares similares
-
Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs
por: Hulsebosch, Sean E., et al.
Publicado: (2022) -
Erratum for “An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats”
Publicado: (2023) -
An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
por: Gilor, Chen, et al.
Publicado: (2021) -
Erratum to “Factors Associated with Long-Term Control of Type 2 Diabetes Mellitus”
por: Badedi, Mohammed, et al.
Publicado: (2019) -
Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients
por: Alsofiani, Wafa A, et al.
Publicado: (2022)